AbbVie | ABBV - Interest Income


AbbVie reported $67M in Interest Income for its fiscal quarter ending in June of 2026.





Interest Income Change Date
AbbVie USD 67M 5M Jun/2026
Abbott USD 106M 28M Mar/2026
ALKERMES USD 6.49M 2.05M Sep/2026
AstraZeneca USD 80M 7M Jun/2026
Biogen USD 25.3M 12.6M Jun/2026
BioMarin Pharmaceutical USD 4.63M 5.85M Sep/2026
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 45M 50M Jun/2026
GlaxoSmithKline GBP 58M 36M Jun/2026
J&J USD 0.09 2.18 Sep/2026
Medtronic USD 114M 23M Jan/2025
Merck USD 35M 0 Jun/2026
Pacira USD 1.94M 14K Jun/2026
Pfizer USD 0.56 0.6 Sep/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sanofi EUR 77M 17M Jun/2026
Ultragenyx Pharmaceutical USD 5M 1000K Jun/2026
United Therapeutics USD 31.5M 10.3M Jun/2026
Vertex Pharmaceuticals USD 118.4M 2.2M Sep/2026
Zoetis USD 16M 5M Jun/2026